Clinical Trial Update: Chemo-free in Older (≥65) Node-Positive ER+/HER2- Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial is exploring a chemo-free treatment strategy for older (≥65) patients with node-positive, ER+/HER2- breast cancer; the study is currently not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer, Adjuvant Therapy | Phase 3 | Status: NOT_YET_RECRUITING